Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Broder

Showing results (211-220 of 451) with videos related to

Pageof 46
Sort By:
Current Medical Research and Opinion|January 17, 2019
Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims dataJennifer Munday, Mallik Greene, Eunice Chang, et al.
Current Medical Research and Opinion|July 27, 2018
Treatment adherence, healthcare resource utilization, and costs in patients with lung neuroendocrine tumors (lung NETs) in the USAMichael S Broder, Beilei Cai, Eunice Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type IS Matsushita, M Robert-Guroff, J Trepel, et al.
Current Medical Research and Opinion|October 24, 2017
All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychoticsTingjian Yan, Mallik Greene, Eunice Chang, et al.
Advances in Therapy|November 21, 2018
Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims DataIrina Yermilov, Mallik Greene, Eunice Chang, et al.
Transactions of the Association of American Physicians|January 1, 1975
Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymomaT A Waldmann, S Broder, M Durm, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 13, 2012
Clinical and economic impact of adhesiolysis during repeat cesarean deliveryVanja Sikirica, Michael S Broder, Eunice Chang, et al.
Pituitary|May 8, 2014
Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United StatesMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2013
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the USTimothy Juday, Todd Correll, Ayanna Anene, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2014
Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the United StatesMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Pageof 46

Showing results (211-220 of 451) with videos related to

Sort By:
Pageof 46
Current Medical Research and Opinion|January 17, 2019
Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims dataJennifer Munday, Mallik Greene, Eunice Chang, et al.
Current Medical Research and Opinion|July 27, 2018
Treatment adherence, healthcare resource utilization, and costs in patients with lung neuroendocrine tumors (lung NETs) in the USAMichael S Broder, Beilei Cai, Eunice Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type IS Matsushita, M Robert-Guroff, J Trepel, et al.
Current Medical Research and Opinion|October 24, 2017
All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychoticsTingjian Yan, Mallik Greene, Eunice Chang, et al.
Advances in Therapy|November 21, 2018
Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims DataIrina Yermilov, Mallik Greene, Eunice Chang, et al.
Transactions of the Association of American Physicians|January 1, 1975
Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymomaT A Waldmann, S Broder, M Durm, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 13, 2012
Clinical and economic impact of adhesiolysis during repeat cesarean deliveryVanja Sikirica, Michael S Broder, Eunice Chang, et al.
Pituitary|May 8, 2014
Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United StatesMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 17, 2013
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the USTimothy Juday, Todd Correll, Ayanna Anene, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 24, 2014
Burden of illness, annual healthcare utilization, and costs associated with commercially insured patients with Cushing disease in the United StatesMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Pageof 46